MedPath

A clinical trial to study the effect of intranasal dexmedetomidine on spinal anaesthesia shivering .

Not Applicable
Conditions
Health Condition 1: 1- Obstetrics
Registration Number
CTRI/2024/08/071988
Lead Sponsor
Sri Venkateswara Institute of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Age between 20-45 years.

2.ASA-PS II and III.

3.Weight between 45 to 75 kgs.

4.Normothermic 36.5 to 37.5 degree C

5.Stable hemodynamics SBP greater than 100mmhg.

Exclusion Criteria

1.Declining to participate or receive spinal anaesthesia.

2.Absolute contraindications to spinal anaesthesia.

3.Height less than 100 cms.

4.Morbid obesity with BMI greater than 40KG/M2 .

5.Known allergy to dexmedetomidine or bupivacaine.

6.Use of epidural catheter.

7.Presence of significant cardiac, liver or renal problems.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
TO DETERMINE THE OCCURENCE OF CLINICALLY SIGNIFICANT POST SPINAL ANAESTHESIA SHIVERINGTimepoint: Immediately after spinal anaesthesia, 5,10,15,20,30,45,60 mins and at the end of the surgery.Post operative every 30 mins for 120 mins
Secondary Outcome Measures
NameTimeMethod
GRADE OF SHIVERING <br/ ><br>GRADE OF SEDATION <br/ ><br>OCCURENCE OF NAUSEA,VOMITING, <br/ ><br>BRADYCARDIA,HYPOTENSION.Timepoint: Immediately after spinal anaesthesia,post spinal at 1,3,5,10,20,30,40,50 min,1,2,4,6 hrs
© Copyright 2025. All Rights Reserved by MedPath